(Q74653973)

English

TIMI 11B. Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: a double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods. Thrombolysis in Myocardial Infar

scientific article published on 01 June 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9628449%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

Europe PubMed Central

TIMI 11B. Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: a double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods. Thrombolysis in Myocardial Infarction (TIMI) 11B Trial Investigators (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9628449%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

unstable angina

1 reference

based on heuristic

inferred from title

myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

E M Antman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9628449%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

0 references

publication date

1 June 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9628449%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9628449%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

135

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9628449%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

6 Pt 3 Su

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9628449%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

S353-60

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9628449%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Aspirin, heparin, or both to treat acute unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Reactivation of unstable angina after the discontinuation of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Are we mortgaging the medical profession?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Thrombin hypothesis of thrombus generation and vascular lesion formation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Activation of blood coagulation by plaque rupture: mechanisms and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Advances in antithrombotic drug therapy for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Persistent activation of coagulation mechanism in unstable angina and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Comparison of the platelet pro-aggregatory effect of conventional unfractionated heparins and a low molecular weight heparin fraction (CY 222).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Enoxaparin. A review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders

2 references

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of thrombin generation by heparin and low molecular weight (LMW) heparins in the absence and presence of platelet factor 4 (PF4)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

A cross-over comparison of the anti-clotting effects of three low molecular weight heparins and glycosaminoglycuronan

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Molecular and cellular biology of blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Enoxaparin for thromboembolism prophylaxis in spinal injury: preliminary report on experience with 105 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

New therapies for unstable angina and non-Q-wave myocardial infarction: recent clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970265-0

7 January 2021

Identifiers

10.1016/S0002-8703(98)70265-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9628449%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9628449%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74653973&oldid=1933534980"